nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—UGT1A1—Sorafenib—thyroid cancer	0.451	0.758	CbGbCtD
Naltrexone—ABCB1—Sorafenib—thyroid cancer	0.0894	0.15	CbGbCtD
Naltrexone—ABCB1—Doxorubicin—thyroid cancer	0.0542	0.0913	CbGbCtD
Naltrexone—Pulmonary embolism—Epirubicin—thyroid cancer	0.000999	0.00246	CcSEcCtD
Naltrexone—Injection site reaction—Epirubicin—thyroid cancer	0.000993	0.00245	CcSEcCtD
Naltrexone—Abnormal dreams—Epirubicin—thyroid cancer	0.000987	0.00243	CcSEcCtD
Naltrexone—Dry mouth—Sorafenib—thyroid cancer	0.000984	0.00243	CcSEcCtD
Naltrexone—Diarrhoea—Vandetanib—thyroid cancer	0.000978	0.00241	CcSEcCtD
Naltrexone—Ulcer—Doxorubicin—thyroid cancer	0.000977	0.00241	CcSEcCtD
Naltrexone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000965	0.00238	CcSEcCtD
Naltrexone—Colitis—Epirubicin—thyroid cancer	0.000959	0.00236	CcSEcCtD
Naltrexone—Infection—Sorafenib—thyroid cancer	0.000958	0.00236	CcSEcCtD
Naltrexone—Shock—Sorafenib—thyroid cancer	0.000949	0.00234	CcSEcCtD
Naltrexone—Nervous system disorder—Sorafenib—thyroid cancer	0.000946	0.00233	CcSEcCtD
Naltrexone—Dizziness—Vandetanib—thyroid cancer	0.000946	0.00233	CcSEcCtD
Naltrexone—Skin disorder—Sorafenib—thyroid cancer	0.000937	0.00231	CcSEcCtD
Naltrexone—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000924	0.00228	CcSEcCtD
Naltrexone—Anorexia—Sorafenib—thyroid cancer	0.000919	0.00227	CcSEcCtD
Naltrexone—Injection site reaction—Doxorubicin—thyroid cancer	0.000919	0.00227	CcSEcCtD
Naltrexone—Abnormal dreams—Doxorubicin—thyroid cancer	0.000914	0.00225	CcSEcCtD
Naltrexone—Vomiting—Vandetanib—thyroid cancer	0.000909	0.00224	CcSEcCtD
Naltrexone—Rash—Vandetanib—thyroid cancer	0.000902	0.00222	CcSEcCtD
Naltrexone—Dermatitis—Vandetanib—thyroid cancer	0.000901	0.00222	CcSEcCtD
Naltrexone—Headache—Vandetanib—thyroid cancer	0.000896	0.00221	CcSEcCtD
Naltrexone—Colitis—Doxorubicin—thyroid cancer	0.000888	0.00219	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000879	0.00217	CcSEcCtD
Naltrexone—Mental disability—Epirubicin—thyroid cancer	0.000867	0.00214	CcSEcCtD
Naltrexone—Dyspnoea—Sorafenib—thyroid cancer	0.00086	0.00212	CcSEcCtD
Naltrexone—Lymphadenopathy—Epirubicin—thyroid cancer	0.00085	0.0021	CcSEcCtD
Naltrexone—Nausea—Vandetanib—thyroid cancer	0.000849	0.00209	CcSEcCtD
Naltrexone—Phlebitis—Epirubicin—thyroid cancer	0.000842	0.00208	CcSEcCtD
Naltrexone—Decreased appetite—Sorafenib—thyroid cancer	0.000838	0.00207	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000833	0.00205	CcSEcCtD
Naltrexone—Fatigue—Sorafenib—thyroid cancer	0.000832	0.00205	CcSEcCtD
Naltrexone—Pain—Sorafenib—thyroid cancer	0.000825	0.00203	CcSEcCtD
Naltrexone—Constipation—Sorafenib—thyroid cancer	0.000825	0.00203	CcSEcCtD
Naltrexone—Mental disability—Doxorubicin—thyroid cancer	0.000802	0.00198	CcSEcCtD
Naltrexone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.0008	0.00197	CcSEcCtD
Naltrexone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000789	0.00194	CcSEcCtD
Naltrexone—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000787	0.00194	CcSEcCtD
Naltrexone—Phlebitis—Doxorubicin—thyroid cancer	0.000779	0.00192	CcSEcCtD
Naltrexone—Hot flush—Epirubicin—thyroid cancer	0.000775	0.00191	CcSEcCtD
Naltrexone—Increased appetite—Epirubicin—thyroid cancer	0.000772	0.0019	CcSEcCtD
Naltrexone—Menopausal symptoms—Epirubicin—thyroid cancer	0.000769	0.00189	CcSEcCtD
Naltrexone—Urticaria—Sorafenib—thyroid cancer	0.000766	0.00189	CcSEcCtD
Naltrexone—Abdominal pain—Sorafenib—thyroid cancer	0.000762	0.00188	CcSEcCtD
Naltrexone—Body temperature increased—Sorafenib—thyroid cancer	0.000762	0.00188	CcSEcCtD
Naltrexone—Purpura—Epirubicin—thyroid cancer	0.000752	0.00185	CcSEcCtD
Naltrexone—Lethargy—Epirubicin—thyroid cancer	0.00074	0.00182	CcSEcCtD
Naltrexone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00074	0.00182	CcSEcCtD
Naltrexone—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000725	0.00179	CcSEcCtD
Naltrexone—Pain in extremity—Epirubicin—thyroid cancer	0.000725	0.00179	CcSEcCtD
Naltrexone—Hot flush—Doxorubicin—thyroid cancer	0.000717	0.00177	CcSEcCtD
Naltrexone—Increased appetite—Doxorubicin—thyroid cancer	0.000714	0.00176	CcSEcCtD
Naltrexone—Migraine—Epirubicin—thyroid cancer	0.000714	0.00176	CcSEcCtD
Naltrexone—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000711	0.00175	CcSEcCtD
Naltrexone—Hypersensitivity—Sorafenib—thyroid cancer	0.000711	0.00175	CcSEcCtD
Naltrexone—Face oedema—Epirubicin—thyroid cancer	0.0007	0.00173	CcSEcCtD
Naltrexone—Purpura—Doxorubicin—thyroid cancer	0.000696	0.00172	CcSEcCtD
Naltrexone—Asthenia—Sorafenib—thyroid cancer	0.000692	0.00171	CcSEcCtD
Naltrexone—Lethargy—Doxorubicin—thyroid cancer	0.000685	0.00169	CcSEcCtD
Naltrexone—Pruritus—Sorafenib—thyroid cancer	0.000682	0.00168	CcSEcCtD
Naltrexone—Dehydration—Epirubicin—thyroid cancer	0.000674	0.00166	CcSEcCtD
Naltrexone—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000671	0.00165	CcSEcCtD
Naltrexone—Pain in extremity—Doxorubicin—thyroid cancer	0.000671	0.00165	CcSEcCtD
Naltrexone—Abdominal pain upper—Epirubicin—thyroid cancer	0.000662	0.00163	CcSEcCtD
Naltrexone—Migraine—Doxorubicin—thyroid cancer	0.000661	0.00163	CcSEcCtD
Naltrexone—Diarrhoea—Sorafenib—thyroid cancer	0.00066	0.00163	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000653	0.00161	CcSEcCtD
Naltrexone—Nasopharyngitis—Epirubicin—thyroid cancer	0.000649	0.0016	CcSEcCtD
Naltrexone—Face oedema—Doxorubicin—thyroid cancer	0.000648	0.0016	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00064	0.00158	CcSEcCtD
Naltrexone—Dizziness—Sorafenib—thyroid cancer	0.000638	0.00157	CcSEcCtD
Naltrexone—Influenza—Epirubicin—thyroid cancer	0.000627	0.00155	CcSEcCtD
Naltrexone—Dehydration—Doxorubicin—thyroid cancer	0.000624	0.00154	CcSEcCtD
Naltrexone—Vomiting—Sorafenib—thyroid cancer	0.000613	0.00151	CcSEcCtD
Naltrexone—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000613	0.00151	CcSEcCtD
Naltrexone—Angina pectoris—Epirubicin—thyroid cancer	0.000611	0.00151	CcSEcCtD
Naltrexone—Rash—Sorafenib—thyroid cancer	0.000608	0.0015	CcSEcCtD
Naltrexone—Dermatitis—Sorafenib—thyroid cancer	0.000608	0.0015	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000604	0.00149	CcSEcCtD
Naltrexone—Headache—Sorafenib—thyroid cancer	0.000604	0.00149	CcSEcCtD
Naltrexone—Bronchitis—Epirubicin—thyroid cancer	0.000603	0.00149	CcSEcCtD
Naltrexone—Nasopharyngitis—Doxorubicin—thyroid cancer	0.0006	0.00148	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000592	0.00146	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000583	0.00144	CcSEcCtD
Naltrexone—Influenza—Doxorubicin—thyroid cancer	0.00058	0.00143	CcSEcCtD
Naltrexone—Nausea—Sorafenib—thyroid cancer	0.000573	0.00141	CcSEcCtD
Naltrexone—Weight increased—Epirubicin—thyroid cancer	0.00057	0.00141	CcSEcCtD
Naltrexone—Weight decreased—Epirubicin—thyroid cancer	0.000567	0.0014	CcSEcCtD
Naltrexone—Angina pectoris—Doxorubicin—thyroid cancer	0.000565	0.00139	CcSEcCtD
Naltrexone—Pneumonia—Epirubicin—thyroid cancer	0.000562	0.00139	CcSEcCtD
Naltrexone—Infestation—Epirubicin—thyroid cancer	0.000559	0.00138	CcSEcCtD
Naltrexone—Infestation NOS—Epirubicin—thyroid cancer	0.000559	0.00138	CcSEcCtD
Naltrexone—Bronchitis—Doxorubicin—thyroid cancer	0.000558	0.00137	CcSEcCtD
Naltrexone—Conjunctivitis—Epirubicin—thyroid cancer	0.000543	0.00134	CcSEcCtD
Naltrexone—Urinary tract infection—Epirubicin—thyroid cancer	0.000543	0.00134	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000539	0.00133	CcSEcCtD
Naltrexone—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000529	0.0013	CcSEcCtD
Naltrexone—Weight increased—Doxorubicin—thyroid cancer	0.000528	0.0013	CcSEcCtD
Naltrexone—Epistaxis—Epirubicin—thyroid cancer	0.000527	0.0013	CcSEcCtD
Naltrexone—Weight decreased—Doxorubicin—thyroid cancer	0.000525	0.00129	CcSEcCtD
Naltrexone—Sinusitis—Epirubicin—thyroid cancer	0.000524	0.00129	CcSEcCtD
Naltrexone—Pneumonia—Doxorubicin—thyroid cancer	0.00052	0.00128	CcSEcCtD
Naltrexone—Infestation NOS—Doxorubicin—thyroid cancer	0.000517	0.00127	CcSEcCtD
Naltrexone—Infestation—Doxorubicin—thyroid cancer	0.000517	0.00127	CcSEcCtD
Naltrexone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000503	0.00124	CcSEcCtD
Naltrexone—Conjunctivitis—Doxorubicin—thyroid cancer	0.000503	0.00124	CcSEcCtD
Naltrexone—Hepatitis—Epirubicin—thyroid cancer	0.000502	0.00124	CcSEcCtD
Naltrexone—Pharyngitis—Epirubicin—thyroid cancer	0.000498	0.00123	CcSEcCtD
Naltrexone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000493	0.00122	CcSEcCtD
Naltrexone—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000489	0.00121	CcSEcCtD
Naltrexone—Epistaxis—Doxorubicin—thyroid cancer	0.000488	0.0012	CcSEcCtD
Naltrexone—Sinusitis—Doxorubicin—thyroid cancer	0.000485	0.0012	CcSEcCtD
Naltrexone—Eye disorder—Epirubicin—thyroid cancer	0.000469	0.00116	CcSEcCtD
Naltrexone—Tinnitus—Epirubicin—thyroid cancer	0.000468	0.00115	CcSEcCtD
Naltrexone—Cardiac disorder—Epirubicin—thyroid cancer	0.000466	0.00115	CcSEcCtD
Naltrexone—Hepatitis—Doxorubicin—thyroid cancer	0.000464	0.00114	CcSEcCtD
Naltrexone—Pharyngitis—Doxorubicin—thyroid cancer	0.000461	0.00114	CcSEcCtD
Naltrexone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000456	0.00112	CcSEcCtD
Naltrexone—Angiopathy—Epirubicin—thyroid cancer	0.000455	0.00112	CcSEcCtD
Naltrexone—Immune system disorder—Epirubicin—thyroid cancer	0.000453	0.00112	CcSEcCtD
Naltrexone—Mediastinal disorder—Epirubicin—thyroid cancer	0.000452	0.00111	CcSEcCtD
Naltrexone—Chills—Epirubicin—thyroid cancer	0.00045	0.00111	CcSEcCtD
Naltrexone—Alopecia—Epirubicin—thyroid cancer	0.000443	0.00109	CcSEcCtD
Naltrexone—Mental disorder—Epirubicin—thyroid cancer	0.00044	0.00108	CcSEcCtD
Naltrexone—Malnutrition—Epirubicin—thyroid cancer	0.000437	0.00108	CcSEcCtD
Naltrexone—Eye disorder—Doxorubicin—thyroid cancer	0.000434	0.00107	CcSEcCtD
Naltrexone—Tinnitus—Doxorubicin—thyroid cancer	0.000433	0.00107	CcSEcCtD
Naltrexone—Cardiac disorder—Doxorubicin—thyroid cancer	0.000431	0.00106	CcSEcCtD
Naltrexone—Flatulence—Epirubicin—thyroid cancer	0.00043	0.00106	CcSEcCtD
Naltrexone—Tension—Epirubicin—thyroid cancer	0.000429	0.00106	CcSEcCtD
Naltrexone—Dysgeusia—Epirubicin—thyroid cancer	0.000428	0.00105	CcSEcCtD
Naltrexone—Nervousness—Epirubicin—thyroid cancer	0.000424	0.00105	CcSEcCtD
Naltrexone—Back pain—Epirubicin—thyroid cancer	0.000422	0.00104	CcSEcCtD
Naltrexone—Angiopathy—Doxorubicin—thyroid cancer	0.000421	0.00104	CcSEcCtD
Naltrexone—Muscle spasms—Epirubicin—thyroid cancer	0.00042	0.00104	CcSEcCtD
Naltrexone—Immune system disorder—Doxorubicin—thyroid cancer	0.000419	0.00103	CcSEcCtD
Naltrexone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000418	0.00103	CcSEcCtD
Naltrexone—Chills—Doxorubicin—thyroid cancer	0.000417	0.00103	CcSEcCtD
Naltrexone—Vision blurred—Epirubicin—thyroid cancer	0.000412	0.00101	CcSEcCtD
Naltrexone—Alopecia—Doxorubicin—thyroid cancer	0.00041	0.00101	CcSEcCtD
Naltrexone—Mental disorder—Doxorubicin—thyroid cancer	0.000407	0.001	CcSEcCtD
Naltrexone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000405	0.000999	CcSEcCtD
Naltrexone—Malnutrition—Doxorubicin—thyroid cancer	0.000404	0.000996	CcSEcCtD
Naltrexone—Agitation—Epirubicin—thyroid cancer	0.000401	0.000989	CcSEcCtD
Naltrexone—Flatulence—Doxorubicin—thyroid cancer	0.000398	0.000982	CcSEcCtD
Naltrexone—Tension—Doxorubicin—thyroid cancer	0.000397	0.000978	CcSEcCtD
Naltrexone—Dysgeusia—Doxorubicin—thyroid cancer	0.000396	0.000976	CcSEcCtD
Naltrexone—Malaise—Epirubicin—thyroid cancer	0.000394	0.000971	CcSEcCtD
Naltrexone—Nervousness—Doxorubicin—thyroid cancer	0.000393	0.000968	CcSEcCtD
Naltrexone—Syncope—Epirubicin—thyroid cancer	0.000392	0.000965	CcSEcCtD
Naltrexone—Back pain—Doxorubicin—thyroid cancer	0.000391	0.000964	CcSEcCtD
Naltrexone—Muscle spasms—Doxorubicin—thyroid cancer	0.000389	0.000958	CcSEcCtD
Naltrexone—Palpitations—Epirubicin—thyroid cancer	0.000386	0.000951	CcSEcCtD
Naltrexone—Loss of consciousness—Epirubicin—thyroid cancer	0.000384	0.000946	CcSEcCtD
Naltrexone—Cough—Epirubicin—thyroid cancer	0.000381	0.000939	CcSEcCtD
Naltrexone—Vision blurred—Doxorubicin—thyroid cancer	0.000381	0.000939	CcSEcCtD
Naltrexone—Convulsion—Epirubicin—thyroid cancer	0.000378	0.000933	CcSEcCtD
Naltrexone—Hypertension—Epirubicin—thyroid cancer	0.000377	0.000929	CcSEcCtD
Naltrexone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000375	0.000924	CcSEcCtD
Naltrexone—Myalgia—Epirubicin—thyroid cancer	0.000372	0.000917	CcSEcCtD
Naltrexone—Arthralgia—Epirubicin—thyroid cancer	0.000372	0.000917	CcSEcCtD
Naltrexone—Chest pain—Epirubicin—thyroid cancer	0.000372	0.000917	CcSEcCtD
Naltrexone—Agitation—Doxorubicin—thyroid cancer	0.000371	0.000915	CcSEcCtD
Naltrexone—Anxiety—Epirubicin—thyroid cancer	0.000371	0.000913	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000369	0.00091	CcSEcCtD
Naltrexone—Discomfort—Epirubicin—thyroid cancer	0.000367	0.000906	CcSEcCtD
Naltrexone—Malaise—Doxorubicin—thyroid cancer	0.000364	0.000898	CcSEcCtD
Naltrexone—Dry mouth—Epirubicin—thyroid cancer	0.000364	0.000896	CcSEcCtD
Naltrexone—Syncope—Doxorubicin—thyroid cancer	0.000362	0.000893	CcSEcCtD
Naltrexone—Confusional state—Epirubicin—thyroid cancer	0.000359	0.000886	CcSEcCtD
Naltrexone—Palpitations—Doxorubicin—thyroid cancer	0.000357	0.00088	CcSEcCtD
Naltrexone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000356	0.000879	CcSEcCtD
Naltrexone—Oedema—Epirubicin—thyroid cancer	0.000356	0.000879	CcSEcCtD
Naltrexone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000355	0.000876	CcSEcCtD
Naltrexone—Infection—Epirubicin—thyroid cancer	0.000354	0.000873	CcSEcCtD
Naltrexone—Cough—Doxorubicin—thyroid cancer	0.000353	0.000869	CcSEcCtD
Naltrexone—Shock—Epirubicin—thyroid cancer	0.000351	0.000864	CcSEcCtD
Naltrexone—Convulsion—Doxorubicin—thyroid cancer	0.00035	0.000863	CcSEcCtD
Naltrexone—Nervous system disorder—Epirubicin—thyroid cancer	0.00035	0.000862	CcSEcCtD
Naltrexone—Hypertension—Doxorubicin—thyroid cancer	0.000349	0.00086	CcSEcCtD
Naltrexone—Tachycardia—Epirubicin—thyroid cancer	0.000348	0.000858	CcSEcCtD
Naltrexone—Skin disorder—Epirubicin—thyroid cancer	0.000346	0.000853	CcSEcCtD
Naltrexone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000345	0.000849	CcSEcCtD
Naltrexone—Chest pain—Doxorubicin—thyroid cancer	0.000344	0.000848	CcSEcCtD
Naltrexone—Arthralgia—Doxorubicin—thyroid cancer	0.000344	0.000848	CcSEcCtD
Naltrexone—Myalgia—Doxorubicin—thyroid cancer	0.000344	0.000848	CcSEcCtD
Naltrexone—Anxiety—Doxorubicin—thyroid cancer	0.000343	0.000845	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000342	0.000842	CcSEcCtD
Naltrexone—Discomfort—Doxorubicin—thyroid cancer	0.00034	0.000838	CcSEcCtD
Naltrexone—Anorexia—Epirubicin—thyroid cancer	0.00034	0.000838	CcSEcCtD
Naltrexone—Dry mouth—Doxorubicin—thyroid cancer	0.000336	0.000829	CcSEcCtD
Naltrexone—Confusional state—Doxorubicin—thyroid cancer	0.000333	0.00082	CcSEcCtD
Naltrexone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00033	0.000813	CcSEcCtD
Naltrexone—Oedema—Doxorubicin—thyroid cancer	0.00033	0.000813	CcSEcCtD
Naltrexone—Infection—Doxorubicin—thyroid cancer	0.000328	0.000808	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000325	0.000801	CcSEcCtD
Naltrexone—Shock—Doxorubicin—thyroid cancer	0.000324	0.0008	CcSEcCtD
Naltrexone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000323	0.000797	CcSEcCtD
Naltrexone—Insomnia—Epirubicin—thyroid cancer	0.000322	0.000795	CcSEcCtD
Naltrexone—Tachycardia—Doxorubicin—thyroid cancer	0.000322	0.000793	CcSEcCtD
Naltrexone—Skin disorder—Doxorubicin—thyroid cancer	0.00032	0.00079	CcSEcCtD
Naltrexone—Paraesthesia—Epirubicin—thyroid cancer	0.00032	0.000789	CcSEcCtD
Naltrexone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000319	0.000786	CcSEcCtD
Naltrexone—Dyspnoea—Epirubicin—thyroid cancer	0.000318	0.000783	CcSEcCtD
Naltrexone—Somnolence—Epirubicin—thyroid cancer	0.000317	0.000781	CcSEcCtD
Naltrexone—Anorexia—Doxorubicin—thyroid cancer	0.000314	0.000775	CcSEcCtD
Naltrexone—Decreased appetite—Epirubicin—thyroid cancer	0.00031	0.000764	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000308	0.000759	CcSEcCtD
Naltrexone—Fatigue—Epirubicin—thyroid cancer	0.000307	0.000758	CcSEcCtD
Naltrexone—Pain—Epirubicin—thyroid cancer	0.000305	0.000751	CcSEcCtD
Naltrexone—Constipation—Epirubicin—thyroid cancer	0.000305	0.000751	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.0003	0.000741	CcSEcCtD
Naltrexone—Insomnia—Doxorubicin—thyroid cancer	0.000298	0.000735	CcSEcCtD
Naltrexone—Paraesthesia—Doxorubicin—thyroid cancer	0.000296	0.00073	CcSEcCtD
Naltrexone—Dyspnoea—Doxorubicin—thyroid cancer	0.000294	0.000725	CcSEcCtD
Naltrexone—Feeling abnormal—Epirubicin—thyroid cancer	0.000294	0.000724	CcSEcCtD
Naltrexone—Somnolence—Doxorubicin—thyroid cancer	0.000293	0.000723	CcSEcCtD
Naltrexone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000291	0.000718	CcSEcCtD
Naltrexone—Decreased appetite—Doxorubicin—thyroid cancer	0.000287	0.000707	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000285	0.000702	CcSEcCtD
Naltrexone—Fatigue—Doxorubicin—thyroid cancer	0.000284	0.000701	CcSEcCtD
Naltrexone—Urticaria—Epirubicin—thyroid cancer	0.000283	0.000698	CcSEcCtD
Naltrexone—Pain—Doxorubicin—thyroid cancer	0.000282	0.000695	CcSEcCtD
Naltrexone—Constipation—Doxorubicin—thyroid cancer	0.000282	0.000695	CcSEcCtD
Naltrexone—Abdominal pain—Epirubicin—thyroid cancer	0.000282	0.000695	CcSEcCtD
Naltrexone—Body temperature increased—Epirubicin—thyroid cancer	0.000282	0.000695	CcSEcCtD
Naltrexone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000272	0.00067	CcSEcCtD
Naltrexone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00027	0.000665	CcSEcCtD
Naltrexone—Hypersensitivity—Epirubicin—thyroid cancer	0.000263	0.000647	CcSEcCtD
Naltrexone—Urticaria—Doxorubicin—thyroid cancer	0.000262	0.000646	CcSEcCtD
Naltrexone—Body temperature increased—Doxorubicin—thyroid cancer	0.000261	0.000643	CcSEcCtD
Naltrexone—Abdominal pain—Doxorubicin—thyroid cancer	0.000261	0.000643	CcSEcCtD
Naltrexone—Asthenia—Epirubicin—thyroid cancer	0.000256	0.00063	CcSEcCtD
Naltrexone—Pruritus—Epirubicin—thyroid cancer	0.000252	0.000622	CcSEcCtD
Naltrexone—Diarrhoea—Epirubicin—thyroid cancer	0.000244	0.000601	CcSEcCtD
Naltrexone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000243	0.000599	CcSEcCtD
Naltrexone—Asthenia—Doxorubicin—thyroid cancer	0.000237	0.000583	CcSEcCtD
Naltrexone—Dizziness—Epirubicin—thyroid cancer	0.000236	0.000581	CcSEcCtD
Naltrexone—Pruritus—Doxorubicin—thyroid cancer	0.000233	0.000575	CcSEcCtD
Naltrexone—Vomiting—Epirubicin—thyroid cancer	0.000227	0.000559	CcSEcCtD
Naltrexone—Diarrhoea—Doxorubicin—thyroid cancer	0.000226	0.000556	CcSEcCtD
Naltrexone—Rash—Epirubicin—thyroid cancer	0.000225	0.000554	CcSEcCtD
Naltrexone—Dermatitis—Epirubicin—thyroid cancer	0.000225	0.000553	CcSEcCtD
Naltrexone—Headache—Epirubicin—thyroid cancer	0.000223	0.00055	CcSEcCtD
Naltrexone—Dizziness—Doxorubicin—thyroid cancer	0.000218	0.000538	CcSEcCtD
Naltrexone—Nausea—Epirubicin—thyroid cancer	0.000212	0.000522	CcSEcCtD
Naltrexone—Vomiting—Doxorubicin—thyroid cancer	0.00021	0.000517	CcSEcCtD
Naltrexone—Rash—Doxorubicin—thyroid cancer	0.000208	0.000513	CcSEcCtD
Naltrexone—Dermatitis—Doxorubicin—thyroid cancer	0.000208	0.000512	CcSEcCtD
Naltrexone—Headache—Doxorubicin—thyroid cancer	0.000207	0.000509	CcSEcCtD
Naltrexone—Nausea—Doxorubicin—thyroid cancer	0.000196	0.000483	CcSEcCtD
